FOXD1 null tumor cells display aberrant cytokinesis and limited proliferation; replicating this phenotype in cancer cells presents an interesting therapeutic approach for ccRCC, and possibly other cancers. The gene discussed is FOXD1; the disease is nonpapillary renal cell carcinoma.